Multiple sclerosis: assay of free immunoglobulin light chains-Reference-Cited by-同舟云学术

Multiple sclerosis: assay of free immunoglobulin light chains

Published:2016-09-28 Issue:1 Volume:54 Page:5-13
ISSN:0004-5632
Container-title:Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
language:en
Short-container-title:Ann Clin Biochem

Author:

Ramsden DB¹

Affiliation:

1. Institute of Metabolism and Systems Research, The Medical School, University of Birmingham, Birmingham, UK

Abstract

Over the past five years, a number of papers have appeared describing the assay of free immunoglobulin light chains in cerebrospinal fluid to assist in the diagnosis of multiple sclerosis. The assay of kappa free immunoglobulin chains is being advocated as a technically simpler and cheaper quantitative alternative to the qualitative detection of oligoclonal bands. This article reviews the analytical and clinical characteristics of these immunoglobulin free light chain assays and places them in their historical context and possible future developments.

Publisher

SAGE Publications

Subject

Clinical Biochemistry,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/0004563216652175

Reference55 articles.

2. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

3. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

4. MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kappa free light chains index in multiple sclerosis very long-term prognosis;Frontiers in Immunology;2023-10-11

2. Prospective multicenter validation of a new laboratory workflow integrating the free light chains kappa quotient in CSF analysis-Protocol of the ORCAS study;2023-07-17

3. Application of oligoclonal bands and other cerebrospinal fluid variables in multiple sclerosis and other neuroimmunological diseases: a narrative review;Annals of Translational Medicine;2023-04

4. Novel CSF Biomarkers Tracking Autoimmune Inflammatory and Neurodegenerative Aspects of CNS Diseases;Diagnostics;2022-12-27

5. A New Laboratory Workflow Integrating the Free Light Chains Kappa Quotient into Routine CSF Analysis;Biomolecules;2022-11-15